secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001437749-25-024862
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Vascular Q2 sales up 15% to $64.2M; raises FY guidance
---------------------------------------------------------------

- Q2 EPS $0.60 (+16% YoY); sales $64.2M (+15% organic) driven by catheters (+27%) and grafts (+19%).
- Gross margin 70.0% (+110 bps); operating income $16.1M (+12%).
- Full-year guidance raised: sales $248-$254M (midpoint +14%), EPS $2.23-$2.37 (midpoint +19%).
- Quarterly dividend of $0.20/share declared, payable Sept 4, 2025 to holders of record Aug 21.
- Cash increased $16.9M sequentially to $319.5M; $75M share repurchase program active through Feb 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/0001437749-25-024862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774925024862/lmat20250805_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-024862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer